These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6429185)

  • 21. Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes.
    Xu DP; Washburn MP; Sun GP; Wells WW
    Biochem Biophys Res Commun; 1996 Apr; 221(1):117-21. PubMed ID: 8660320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase.
    Roth RA
    Biochem Biophys Res Commun; 1981 Jan; 98(2):431-8. PubMed ID: 7013763
    [No Abstract]   [Full Text] [Related]  

  • 23. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of thymus extracts on the chemotaxis of polymorphonuclear neutrophils (PMN) from patients with insulin-dependent diabetes mellitus (IDD).
    Wysocki J; Wierusz-Wysocka B; Wykretowicz A; Wysocki H
    Thymus; 1992 Aug; 20(1):63-7. PubMed ID: 1519313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular distribution of nitroblue tetrazolium reductase (NBT-R) in human polymorphonuclear leukocytes (PMN).
    Baehner RL
    J Lab Clin Med; 1975 Nov; 86(5):785-92. PubMed ID: 1185038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental effects on glutathione-insulin transhydrogenase in rat liver.
    Petri W; Rodriguez J; Pitot HC
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):610-4. PubMed ID: 967893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus--a comparative study of conventional radiometric function tests and low-light imaging systems.
    Marhoffer W; Stein M; Schleinkofer L; Federlin K
    J Biolumin Chemilumin; 1994; 9(3):165-70. PubMed ID: 7942121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactive insulin and insulin degrading enzymes in erythrocytes. A preliminary report.
    Snehalatha C; Timothy H; Mohan V; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):558-61. PubMed ID: 2246195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis.
    Schaefer RM; Herfs N; Ormanns W; Hörl WH; Heidland A
    Clin Nephrol; 1988 Jun; 29(6):307-11. PubMed ID: 3396234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of thymus extract (TFX) on the phagocytosis and the bactericidal capacity of polymorphonuclear neutrophils from patients with insulin-dependent diabetes mellitus.
    Wysocki H; Kiczka W; Wierusz-Wysocka B; Szczepanik A; Czarnecki J
    Thymus; 1985; 7(5):271-8. PubMed ID: 4060215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
    Stentz FB; Harris HL; Kitabchi AE
    Endocrinology; 1985 Mar; 116(3):926-34. PubMed ID: 3882399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antioxidant enzymes in insulin-dependent diabetes in the child and adolescent].
    Jos J; Rybak M; Patin PH; Robert JJ; Boitard C; Thevenin R
    Diabete Metab; 1990 Dec; 16(6):498-503. PubMed ID: 2086281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin degradation. XVI. Evidence for the sequential degradative pathway in isolated liver cells.
    Varandani PT; Nafz MA
    Diabetes; 1976 Mar; 25(3):173-9. PubMed ID: 815121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin binding to monocytes and total mononuclear leukocytes from normal and diabetic patients.
    Olefsky JM; Reaven GM
    J Clin Endocrinol Metab; 1976 Jul; 43(1):226-31. PubMed ID: 947940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turnover of hepatic glutathione-insulin transhydrogenase (disulfide interchange enzyme) in normal and diabetic rats utilizing a new simplified isolation procedure.
    Hern EP; Varandani PT
    J Biol Chem; 1980 Jan; 255(2):697-703. PubMed ID: 6766132
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiol-protein disulfide oxidoreductase and peptidase activities in insulinoma tissue.
    Kohnert KD; Hehmke B; Woltanski KP; Ulrich FE; Zühlke H
    Biomed Biochim Acta; 1983; 42(9):1091-101. PubMed ID: 6322744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diabetes and insulin therapy on human mononuclear leukocyte lysosomal acid lipase activity.
    Finegold DN; Coates PM
    Metabolism; 1984 Jan; 33(1):85-9. PubMed ID: 6361450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased deformability of polymorphonuclear leukocytes in diabetic cats.
    Braun RD; Fisher TC; Meiselman HJ; Hatchell DL
    Microcirculation; 1996 Sep; 3(3):271-8. PubMed ID: 8930884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUTATHIONE-INSULIN TRANSHYDROGENASE OF HUMAN LIVER.
    TOMIZAWA HH; VARANDANI PT
    J Biol Chem; 1965 Jul; 240():3191-4. PubMed ID: 14342351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.